Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
| Revision | Operations | |
|---|---|---|
| 10-11-24 by kaipe | current revision | |
| 10-10-24 by kaipe | ||
| 10-8-24 by kaipe | ||
| 10-8-24 by kaipe | ||
| 10-8-24 by kaipe | ||
| 10-7-24 by kaipe | ||
| 10-7-24 by kaipe | ||
| 09-24-24 by kaipe | ||
| 08-30-24 by [email protected] | ||
| 08-15-24 by [email protected] | ||
| 08-15-24 by [email protected] | ||
| 01-18-23 by kaipe | ||
| 01-18-23 by kaipe | ||
| 01-11-23 by kaipe | ||
| 01-11-23 by kaipe | ||
| 02-17-22 by [email protected] | ||
| 10-20-20 by conan.macdougal... | ||
| 08-26-20 by conan.macdougal... | ||
| 08-21-20 by [email protected] | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 07-10-20 by [email protected] | ||
| 06-23-20 by conan.macdougal... | ||
| 04-21-20 by ucsf_admin | ||
Dosing: Adult Antimicrobial Dosing, Non-dialysis
Extended Infusion Dosing (PREFERRED for UCSF)
| Indication | CrCl > 20 mL/min | <20 mL/min |
|---|---|---|
|
UCSF: All Infections, including documented/suspected Pseudomonas UCSF exclusion criteria for EXTENDED INFUSION: resistant or intermediate susceptibility organism, cystic fibrosis, peri-procedural areas, insufficient IV access ZSFG: Use EXTENDED INFUSION when recommended by ID pharmacist or ID fellow |
Loading dose = 4.5 g IV over 30 min x1, then 4.5 g IV infused over 4h every 8h (starting immediately after loading dose) |
Use SHORT INFUSION piperacillin/tazobactam |
See Adult Extended Infusion Piperacillin-Tazobactam protocol for additional details
Short Infusion Dosing
| Indication | > 50 mL/min | 10 – 50 mL/min | < 10 mL/min |
|---|---|---|---|
|
UCSF: Use SHORT INFUSION only for patients excluded from EXTENDED INFUSION dosing ZSFG: Use SHORT INFUSION unless EXTENDED infusion is recommended by ID |
|||
|
Non-Pseudomonas infections |
3.375 g IV q6h |
3.375 g IV q8h |
2.25 g IV q8h |
| Documented/Suspected Pseudomonas aeruginosa infection |
CrCl > 20 mL/min: 4.5 g IV q6h |
CrCl < 20 mL/min: 3.375 g IV q8h |
|
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
|
Indication |
Intermittent Hemodialysis |
Continuous Hemodialysis |
|---|---|---|
|
UCSF: All Infections, including documented/suspected Pseudomonas UCSF: Exclusion criteria for EXTENDED INFUSION: resistant or intermediate susceptibility organism, cystic fibrosis, peri-procedural areas, insufficient IV access |
2.25 g IV q8h (SHORT infusion over 30 minutes) |
UCSF: Loading dose = 4.5 g IV over 30 min x1, then 4.5 g IV infused over 4h every 8h (starting immediately after loading dose) ZSFG: 4.5 g IV q8h (SHORT infusion over 30 minutes) |
Dialysis Notes
Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min.
UCSF: Extended infusion is the PREFERRED dosing strategy if no exclusions
ZSFG: Available upon ID pharmacy or ID fellow recommendation